Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-12-039638
Filing Date
2012-09-06
Accepted
2012-09-06 16:03:19
Documents
1
Period of Report
2012-08-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 8265
  Complete submission text file 0001140361-12-039638.txt   10999
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVENUE 12TH FLOOR NEW YORK NY 10153
Business Address
Slager David Mark (Reporting) CIK: 0001477733 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50298 | Film No.: 121076956

Mailing Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153 212-256-8402
Regals Fund LP (Reporting) CIK: 0001542836 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-50298 | Film No.: 121076957

Mailing Address 152 WEST 57TH STREET 9TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 9TH FLOOR NEW YORK NY 10019 212-256-8402
REGALS CAPITAL MANAGEMENT LP (Reporting) CIK: 0001542838 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-50298 | Film No.: 121076958